Comparison of ondansetron with a combined regimen of alizapride and methylprednisolone in the prophylaxis of cisplatin-induced emesis in patients with lung cancer

This publication has 18 references indexed in Scilit:

• Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting
  Annals of Internal Medicine, 1990
• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
  Journal of Clinical Oncology, 1989
• GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting
  Cancer Chemotherapy and Pharmacology, 1989
• Antiemetic Efficacy of Escalating Doses of Alizapride against Chemotherapy-Induced Emesis
  Oncology, 1989
• Phase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by Cisplatin
  JNCI Journal of the National Cancer Institute, 1989
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT₃ receptors
  British Journal of Pharmacology, 1988
• Antiemetic properties of the 5HT3-receptor antagonist, gr38032f
  Cancer Treatment Reviews, 1987
• Emesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting
  European Journal of Cancer and Clinical Oncology, 1984
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981